AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...

The issuer is solely responsible for the content of this announcement.

HONG KONG SAR – media OutReach Newswire – 5 February 2025 – AIM Vaccine Co., Ltd. (06660), a leading PRC vaccine company, announced today that its independently developed mRNA RSV ...

(MENAFN- Dubai PR Network) data-text="AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S." data-link=" Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S." class ...

It’s little comfort that the list of roughly 30 bills backed by Texans for Vaccine Choice is down from about 50 during the ...

The bills would restrict how employers treat vaccination and require a reporting system for "vaccine injuries." ...